The Licorice Flavonols segmentation by application delineates four primary demand clusters that collectively shape the market’s revenue profile. Food & Beverages accounts for the largest share (≈45 %), driven by the compound’s sweetening capacity and antioxidant properties, which enable manufacturers to formulate reduced‑sugar confectionery, dairy alternatives, and functional drinks. Pharmaceuticals contributes roughly 30 % as flavonols are incorporated into anti‑inflammatory, hepatoprotective, and antiviral formulations, leveraging clinically validated bioactivities to justify premium pricing. Cosmetics represents about 15 % of the market, where the UV‑absorbing and skin‑brightening effects of licorice flavonols support anti‑aging creams, serums, and sunscreen products. Finally, Nutraceuticals comprise the remaining 10 %, reflecting the growth of dietary supplements that market these phytochemicals for cardiovascular health and metabolic regulation. The proportional distribution of these segments directly informs production scaling, pricing strategies, and R&D investment across the Licorice Flavonols market.